JP2013537901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537901A5 JP2013537901A5 JP2013529758A JP2013529758A JP2013537901A5 JP 2013537901 A5 JP2013537901 A5 JP 2013537901A5 JP 2013529758 A JP2013529758 A JP 2013529758A JP 2013529758 A JP2013529758 A JP 2013529758A JP 2013537901 A5 JP2013537901 A5 JP 2013537901A5
- Authority
- JP
- Japan
- Prior art keywords
- aprepitant
- proline
- neuropsychiatric
- pruritus
- cancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38574410P | 2010-09-23 | 2010-09-23 | |
| US61/385,744 | 2010-09-23 | ||
| US201161439654P | 2011-02-04 | 2011-02-04 | |
| US61/439,654 | 2011-02-04 | ||
| US201161498214P | 2011-06-17 | 2011-06-17 | |
| US61/498,214 | 2011-06-17 | ||
| PCT/IB2011/054210 WO2012038937A1 (en) | 2010-09-23 | 2011-09-23 | Aprepitant l-proline composition and cocrystal |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537901A JP2013537901A (ja) | 2013-10-07 |
| JP2013537901A5 true JP2013537901A5 (OSRAM) | 2016-02-12 |
| JP5997162B2 JP5997162B2 (ja) | 2016-09-28 |
Family
ID=44907915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013529758A Active JP5997162B2 (ja) | 2010-09-23 | 2011-09-23 | アプレピタントｌ−プロリン組成物および共結晶 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9029369B2 (OSRAM) |
| EP (1) | EP2618828B1 (OSRAM) |
| JP (1) | JP5997162B2 (OSRAM) |
| KR (1) | KR101833578B1 (OSRAM) |
| CN (1) | CN103221049B (OSRAM) |
| AR (1) | AR083095A1 (OSRAM) |
| AU (1) | AU2011306391B2 (OSRAM) |
| BR (1) | BR112013006651A2 (OSRAM) |
| CA (1) | CA2846460C (OSRAM) |
| ES (1) | ES2616752T3 (OSRAM) |
| IL (1) | IL225443A0 (OSRAM) |
| TW (1) | TWI540131B (OSRAM) |
| WO (1) | WO2012038937A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2616752T3 (es) | 2010-09-23 | 2017-06-14 | Nuformix Limited | Composición y cocristal de aprepitant L-prolina |
| US9532993B2 (en) | 2011-11-25 | 2017-01-03 | Nuformix Limited | Aprepitant L-proline solvates—compositions and cocrystals |
| US10098859B2 (en) | 2012-09-05 | 2018-10-16 | Amri Ssci, Llc | Cocrystals of p-coumaric acid |
| WO2015101596A2 (en) * | 2013-12-30 | 2015-07-09 | Oncoprevent Gmbh | Neurokinin-1 receptor antagonists for use in a method of prevention of cancer |
| MX2020008326A (es) * | 2018-02-07 | 2020-09-28 | Reata Pharmaceuticals Inc | Formas de co-cristales de un analogo de novobiocina y prolina. |
| CN116283947A (zh) * | 2023-02-07 | 2023-06-23 | 成都医学院 | 一种阿瑞匹坦共晶及其制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5719147A (en) | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
| ZA985765B (en) | 1997-07-02 | 1999-08-04 | Merck & Co Inc | Polymorphic form of a tachykinin receptor antagonist. |
| MXPA05000232A (es) | 2002-06-21 | 2005-06-17 | Transform Pharmaceuticals Inc | Composiciones farmaceuticas con disolucion mejorada. |
| AU2003272270A1 (en) * | 2003-02-28 | 2004-09-28 | The Regents Of The University Of Michigan | Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| EP2034952A4 (en) * | 2006-06-16 | 2011-08-17 | Reddys Lab Ltd Dr | APREPITANT COMPOSITIONS |
| WO2009108828A2 (en) | 2008-02-27 | 2009-09-03 | Dr. Reddy's Laboratories Ltd. | Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| ES2616752T3 (es) | 2010-09-23 | 2017-06-14 | Nuformix Limited | Composición y cocristal de aprepitant L-prolina |
-
2011
- 2011-09-23 ES ES11779217.6T patent/ES2616752T3/es active Active
- 2011-09-23 BR BR112013006651A patent/BR112013006651A2/pt not_active Application Discontinuation
- 2011-09-23 JP JP2013529758A patent/JP5997162B2/ja active Active
- 2011-09-23 EP EP11779217.6A patent/EP2618828B1/en active Active
- 2011-09-23 CA CA2846460A patent/CA2846460C/en active Active
- 2011-09-23 AR ARP110103486 patent/AR083095A1/es unknown
- 2011-09-23 CN CN201180055997.5A patent/CN103221049B/zh active Active
- 2011-09-23 WO PCT/IB2011/054210 patent/WO2012038937A1/en not_active Ceased
- 2011-09-23 AU AU2011306391A patent/AU2011306391B2/en active Active
- 2011-09-23 US US13/825,380 patent/US9029369B2/en active Active
- 2011-09-23 TW TW100134362A patent/TWI540131B/zh active
- 2011-09-23 KR KR1020137010228A patent/KR101833578B1/ko active Active
-
2013
- 2013-03-21 IL IL225443A patent/IL225443A0/en active IP Right Grant